Based on our previous finding that simvastatin, an inhibitor of key enzymes of the MVA pathway, inhibits the proliferation and metastasis of BLCA cells, we confirmed that it affects the cell cycle distribution of BLCA cells through the PPARγ signaling pathway13. The gene discussed is PPARG; the disease is bladder transitional cell carcinoma.